Bharat Serums' Acquisition Is Very Attractive From A Financial, R&D Perspective: Mankind Pharma
HTML-код
- Опубликовано: 19 окт 2024
- Bharat Serums' acquisition will be funded via internal accruals says Mankind Pharma's Vice Chairman & MD Rajeev Juneja. Tells Ekta Batra that the acquisition will be closed by end of the year.
#mankindpharma #acquisition #stockmarket #stockmarketnews #stockmarketupdates #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday
🔴CNBC TV18 LIVE TV: ruclips.net/user/li...
SUBSCRIBE to our Channel: bit.ly/3nvEcxf
---------------------------------------------------------------------------------------------------------------------
👑 Check Out Top CNBC TV18 Playlist Videos:
🔹Lok Sabha Elections 2024: • Playlist
🔹CNBC TV18 Digital Podcast: • I Did It My Way - CNBC...
🔹Sounding Board: • Sounding Board | CNBC ...
🔹International Videos: • World News - CNBC-TV18
🔹CNBC TV18 Market Cafe: • CNBC TV18 Market Cafe
🔹CNBC TV18 Digital: • CNBC-TV18 Digital Videos
🔹CNBC TV18 Weekend Special: • CNBC-TV18 Weekend Special
🔹CNBC TV18 Next-Gen: • CNBCTV18 Next-Gen
🔹Overdrive Show: • OVERDRIVE || CNBC TV18
🔹Young Turks: • YOUNG TURKS - The Entr...
🔹Starup Streets: • Startup Street
------------------------------------------------------------------------------------
You can also connect with CNBC-TV18 News Online
Catch the latest news: bit.ly/2YbpXBM
Follow CNBC-TV18 round the clock: www.cnbctv18.c...
Stay updated with all the market action in real time: www.cnbctv18.c...
You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: www.cnbctv18.c...
Like us on Facebook: / cnbctv18india
Follow us on Twitter: / cnbctv18news
Follow us on Instagram: / cnbctv18india
Catch us on: Linkedin: / cnbc-tv18
n18oc_business
About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.
Direct questions... straight to the point. Better than the company's latest concall.❤